호흡기 진단 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 유형별, 검사 유형별, 질환 적응증별, 최종 용도별, 지역별, 경쟁별 세분화(2020-2030년)

Respiratory Diagnostics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Test Type, By Disease Indication, By End-Use, By Region and Competition, 2020-2030F

US $ 4,500 ￦ 6,708,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 8,199,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,926,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 호흡기 진단 시장은 2024년에 60억 2,000만 달러로 평가되며, 2030년까지 CAGR 7.10%로 성장하며, 90억 9,000만 달러에 달할 것으로 예측됩니다. 세계 호흡기 진단 시장은 천식, 만성폐쇄성폐질환, 각종 감염성 질환 등 호흡기에 영향을 미치는 질환의 식별, 모니터링, 관리에 사용되는 다양한 의료 검사, 기기, 분석, 서비스를 포함합니다. 이러한 시장 확대는 주로 전 세계 호흡기 질환의 유병률 증가, 이러한 질환에 취약한 고령 인구 증가, 진단의 정확성과 효율성을 향상시키는 지속적인 기술 발전에 의해 주도되고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	60억 2,000만 달러
시장 규모 : 2030년	90억 9,000만 달러
CAGR : 2025-2030년	7.10%
가장 빠르게 성장하는 부문	어세이 및 시약
최대 시장	북미

주요 시장 성장 촉진요인

호흡기 질환 증가 추세는 세계 호흡기 진단 시장의 기본적인 시장 성장 촉진요인이며, 종합적인 진단 솔루션에 대한 수요를 직접적으로 자극하고 있습니다. 천식, 만성폐쇄성폐질환, 각종 감염성 질환은 전 세계에서 공중보건의 심각한 문제로 대두되고 있으며, 효과적인 환자 관리를 위해서는 신속하고 정확한 검출이 필수적입니다.

주요 시장 과제

첨단 진단 장비에 필요한 막대한 자본 투자는 세계 호흡기 진단 시장의 성장을 직접적으로 저해하고 있습니다. 특히 신흥 경제국의 의료 시스템 및 의료 서비스 프로바이더는 예산의 제약이 매우 심해 이러한 필수 기술을 도입하거나 업데이트하는 데 한계가 있습니다.

주요 시장 동향

인공지능(AI)과 머신러닝의 진단 분야로의 통합은 질병 검출의 정확성과 효율성을 높여 전 세계 호흡기 진단 시장을 크게 변화시키고 있습니다. 이러한 첨단 계산 기법을 통해 복잡한 데이터를 빠르게 분석할 수 있으며, 기존 방법보다 더 빨리 호흡기 질환을 나타내는 미묘한 패턴을 파악할 수 있습니다.

목차

제1장 개요

제2장 조사 방법

제3장 개요

제4장 고객의 소리

제5장 세계의 호흡기 진단 시장 전망

• 시장 규모·예측
  • 금액별
• 시장 점유율·예측
  • 유형별(기구·기기, 어세이·시약, 서비스·소프트웨어)
  • 검사 유형별(기계적 검사, OSA 진단 검사, 영상 검사, 기존형 진단 검사, 분자진단 검사)
  • 질환별(결핵, 천식, 폐암, 만성폐쇄성폐질환, 기타)
  • 용도별(병원·진료소, 진단 검사실, 기타)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 호흡기 진단 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 호흡기 진단 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 호흡기 진단 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 호흡기 진단 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 호흡기 진단 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 촉진요인
• 과제

제12장 시장 동향과 발전

• 합병·인수
• 제품 출시
• 최근 동향

제13장 세계의 호흡기 진단 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• Koninklijke Philips N.V
• Becton, Dickinson and Company
• Thermo Fisher Scientific Inc.
• Abbott Laboratories Inc.
• Dragerwerk AG & Co. KGaA
• Siemens Healthineers AG
• PerkinElmer Inc.
• India Medtronic Private Limited
• Bio-Rad Laboratories, Inc.
• GE HealthCare Technologies Inc.

제16장 전략적 제안

제17장 조사회사 소개·면책사항

KSA

영문 목차

영문목차

The Global Respiratory Diagnostics Market, valued at USD 6.02 Billion in 2024, is projected to experience a CAGR of 7.10% to reach USD 9.09 Billion by 2030. The global respiratory diagnostics market encompasses a diverse range of medical tests, devices, assays, and services utilized for the identification, monitoring, and management of conditions affecting the respiratory system, including asthma, chronic obstructive pulmonary disease, and various infections. This market's expansion is primarily driven by the escalating worldwide prevalence of respiratory diseases, the growing elderly population exhibiting higher susceptibility to such conditions, and continuous technological advancements that enhance diagnostic precision and efficiency.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 6.02 Billion
Market Size 2030	USD 9.09 Billion
CAGR 2025-2030	7.10%
Fastest Growing Segment	Assays & Reagents
Largest Market	North America

Key Market Drivers

The increasing prevalence of respiratory diseases represents a fundamental driver for the global respiratory diagnostics market, directly stimulating the demand for comprehensive diagnostic solutions. Conditions such as asthma, chronic obstructive pulmonary disease, and various infections continue to pose substantial public health challenges worldwide, necessitating timely and accurate detection for effective patient management. As populations grow and environmental factors contribute to disease incidence, the imperative for robust diagnostic capabilities intensifies.

Key Market Challenges

The significant capital investment needed for advanced diagnostic equipment directly impedes the growth of the Global Respiratory Diagnostics Market. Healthcare systems and providers, particularly within emerging economies, face considerable budget constraints that limit their capacity to acquire and upgrade such essential technology. This financial barrier often delays the adoption of new, more effective diagnostic solutions, thereby restricting overall market expansion.

Key Market Trends

The integration of Artificial Intelligence and Machine Learning in diagnostics significantly reshapes the Global Respiratory Diagnostics Market by enhancing the precision and efficiency of disease detection. These advanced computational methods enable rapid analysis of complex data, identifying subtle patterns indicative of respiratory conditions earlier than traditional means.

Key Market Players

• Koninklijke Philips N.V
• Becton, Dickinson and Company
• Thermo Fisher Scientific Inc.
• Abbott Laboratories Inc.
• Dragerwerk AG & Co. KGaA
• Siemens Healthineers AG
• PerkinElmer Inc.
• India Medtronic Private Limited
• Bio-Rad Laboratories, Inc.
• GE HealthCare Technologies Inc.

Report Scope:

In this report, the Global Respiratory Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Respiratory Diagnostics Market, By Type:

• Instruments and Devices
• Assays & Reagents
• Services & Software

Respiratory Diagnostics Market, By Test Type:

• Mechanical Tests
• OSA Diagnostic Test
• Imaging Tests
• Traditional Diagnostic Test
• Molecular Diagnostic Tests

Respiratory Diagnostics Market, By Disease Indication:

• Tuberculosis
• Asthma
• Lung Cancer
• Chronic Obstructive Pulmonary Disease
• Others

Respiratory Diagnostics Market, By End-Use:

• Hospitals and Clinics
• Diagnostics Laboratory
• Others

Respiratory Diagnostics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Respiratory Diagnostics Market.

Available Customizations:

Global Respiratory Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Respiratory Diagnostics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Instruments and Devices, Assays & Reagents, Services & Software)
  • 5.2.2. By Test Type (Mechanical Tests, OSA Diagnostic Test, Imaging Tests, Traditional Diagnostic Test, Molecular Diagnostic Tests)
  • 5.2.3. By Disease Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others)
  • 5.2.4. By End-Use (Hospitals and Clinics, Diagnostics Laboratory, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Respiratory Diagnostics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Test Type
  • 6.2.3. By Disease Indication
  • 6.2.4. By End-Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Respiratory Diagnostics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Test Type
      • 6.3.1.2.3. By Disease Indication
      • 6.3.1.2.4. By End-Use
  • 6.3.2. Canada Respiratory Diagnostics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Test Type
      • 6.3.2.2.3. By Disease Indication
      • 6.3.2.2.4. By End-Use
  • 6.3.3. Mexico Respiratory Diagnostics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Test Type
      • 6.3.3.2.3. By Disease Indication
      • 6.3.3.2.4. By End-Use

7. Europe Respiratory Diagnostics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Test Type
  • 7.2.3. By Disease Indication
  • 7.2.4. By End-Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Respiratory Diagnostics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Test Type
      • 7.3.1.2.3. By Disease Indication
      • 7.3.1.2.4. By End-Use
  • 7.3.2. France Respiratory Diagnostics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Test Type
      • 7.3.2.2.3. By Disease Indication
      • 7.3.2.2.4. By End-Use
  • 7.3.3. United Kingdom Respiratory Diagnostics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Test Type
      • 7.3.3.2.3. By Disease Indication
      • 7.3.3.2.4. By End-Use
  • 7.3.4. Italy Respiratory Diagnostics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Test Type
      • 7.3.4.2.3. By Disease Indication
      • 7.3.4.2.4. By End-Use
  • 7.3.5. Spain Respiratory Diagnostics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Test Type
      • 7.3.5.2.3. By Disease Indication
      • 7.3.5.2.4. By End-Use

8. Asia Pacific Respiratory Diagnostics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Test Type
  • 8.2.3. By Disease Indication
  • 8.2.4. By End-Use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Respiratory Diagnostics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Test Type
      • 8.3.1.2.3. By Disease Indication
      • 8.3.1.2.4. By End-Use
  • 8.3.2. India Respiratory Diagnostics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Test Type
      • 8.3.2.2.3. By Disease Indication
      • 8.3.2.2.4. By End-Use
  • 8.3.3. Japan Respiratory Diagnostics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Test Type
      • 8.3.3.2.3. By Disease Indication
      • 8.3.3.2.4. By End-Use
  • 8.3.4. South Korea Respiratory Diagnostics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Test Type
      • 8.3.4.2.3. By Disease Indication
      • 8.3.4.2.4. By End-Use
  • 8.3.5. Australia Respiratory Diagnostics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Test Type
      • 8.3.5.2.3. By Disease Indication
      • 8.3.5.2.4. By End-Use

9. Middle East & Africa Respiratory Diagnostics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Test Type
  • 9.2.3. By Disease Indication
  • 9.2.4. By End-Use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Respiratory Diagnostics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Test Type
      • 9.3.1.2.3. By Disease Indication
      • 9.3.1.2.4. By End-Use
  • 9.3.2. UAE Respiratory Diagnostics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Test Type
      • 9.3.2.2.3. By Disease Indication
      • 9.3.2.2.4. By End-Use
  • 9.3.3. South Africa Respiratory Diagnostics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Test Type
      • 9.3.3.2.3. By Disease Indication
      • 9.3.3.2.4. By End-Use

10. South America Respiratory Diagnostics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Test Type
  • 10.2.3. By Disease Indication
  • 10.2.4. By End-Use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Respiratory Diagnostics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Test Type
      • 10.3.1.2.3. By Disease Indication
      • 10.3.1.2.4. By End-Use
  • 10.3.2. Colombia Respiratory Diagnostics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Test Type
      • 10.3.2.2.3. By Disease Indication
      • 10.3.2.2.4. By End-Use
  • 10.3.3. Argentina Respiratory Diagnostics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Test Type
      • 10.3.3.2.3. By Disease Indication
      • 10.3.3.2.4. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Respiratory Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Koninklijke Philips N.V
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Becton, Dickinson and Company
• 15.3. Thermo Fisher Scientific Inc.
• 15.4. Abbott Laboratories Inc.
• 15.5. Dragerwerk AG & Co. KGaA
• 15.6. Siemens Healthineers AG
• 15.7. PerkinElmer Inc.
• 15.8. India Medtronic Private Limited
• 15.9. Bio-Rad Laboratories, Inc.
• 15.10. GE HealthCare Technologies Inc.

16. Strategic Recommendations

17. About Us & Disclaimer

관련자료